Clinical Trial Update: Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of palifosfamide for recurrent germ cell tumors was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extragonadal Germ Cell Tumor
• Extragonadal Non-seminomatous Germ Cell Tumor
• Extragonadal Seminoma
• Germ Cell Tumor of the Central Nervous System
• Ovarian Germ Cell Tumor
• Teratoma
• Testicular Germ Cell Tumor

Drugs mentioned

• Palifosfamide (palifosfamide)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Adult Central Nervous System Germ Cell Tumor, Adult Teratoma | Phase 2 | Status: TERMINATED | Results posted: 2015-07-02